Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -1.72% | -33.18% | -41.60% |
May. 15 | Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating | MT |
May. 14 | Top Midday Decliners | MT |
Chart calendar Akoya Biosciences, Inc.
Upcoming events on Akoya Biosciences, Inc.
Past events on Akoya Biosciences, Inc.
2024-05-13 05:00 pm | Q1 2024 Earnings Call |
2024-05-13 04:00 pm | Q1 2024 Earnings Release |
2024-03-04 05:00 pm | Q4 2023 Earnings Call |
2024-03-04 04:05 pm | Q4 2023 Earnings Release |
2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
2024-01-10 06:45 pm | JPMorgan Healthcare Conference |
2024-01-07 08:00 am | Q1 2023 Sales and Revenue Release |
2023-11-30 11:30 am | Piper Sandler Healthcare Conference |
2023-11-16 02:30 pm | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
2023-11-15 12:00 pm | Stephens Investment Conference |
2023-11-08 05:00 pm | Q3 2023 Earnings Call |
2023-11-08 04:00 pm | Q3 2023 Earnings Release |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 570 |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 90 |
2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 124 |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 105 |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 117 |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 97 |
2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Poster Number 75 |
2023-09-13 10:10 am | Morgan Stanley Global Healthcare Conference |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 42,4 | 54,9 54,7 0.37% | 74,9 74,1 0.99% | 96,6 96,3 0.37% | 108 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -34,6 -29,0 -19.23% | -59,4 -55,6 -6.82% | -49,6 -50,6 1.9% | -31,2 |
EBIT Million USD | Released Forecast Spread | 0,00 | -39,3 -33,0 -18.99% | -66,1 -62,9 -5.04% | -57,7 -60,2 4.14% | -40,8 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -43,1 -36,4 -18.5% | -70,5 -67,6 -4.31% | -63,3 -65,4 3.26% | -49,4 |
Net income Million USD | Released Forecast Spread | -16,7 | -44,4 -37,3 -18.95% | -70,6 -67,8 -4.2% | -63,3 -66,1 4.21% | -51,6 |
EPS USD | Released Forecast Spread | -9,18 | -1,65 -2,41 31.44% | -1,87 -1,81 -3.09% | -1,43 -1,48 3.08% | -1,10 |
Announcement Date | 26/03/21 | 14/03/22 | 06/03/23 | 04/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 16,9 14,9 13.13% | 17,9 16,9 5.73% | 18,9 17,7 6.76% | 21,2 20,5 3.72% | 21,4 20,3 5.36% | 23,5 22,4 4.82% | 25,2 24,5 2.75% | 26,5 26,1 1.44% | 18,4 24,3 -24.43% | 24,7 | 29,3 | 34,0 | 27,3 | 30,4 |
EBITDA Million USD | Released Forecast Spread | -14,0 -14,5 3.04% | -14,7 -12,3 -19.44% | -14,8 -13,0 -14.14% | -15,8 -13,2 -20.24% | -15,5 -14,9 -3.47% | -17,4 -13,4 -30.21% | -9,18 -11,5 19.86% | -7,57 -9,66 21.71% | -10,8 | -8,68 | -4,03 | -1,60 | -5,97 | -3,67 |
EBIT Million USD | Released Forecast Spread | -15,6 -13,2 -17.54% | -16,3 -12,6 -29.94% | -16,7 -15,8 -5.49% | -17,6 -15,4 -14.44% | -17,4 -17,3 -0.85% | -19,2 -16,4 -17.33% | -11,6 -15,0 22.93% | -9,44 -12,2 22.73% | -15,2 -13,1 -15.79% | -11,5 | -7,62 | -4,51 | -9,65 | -7,87 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,4 -14,2 -15.6% | -17,4 -12,7 -36.56% | -17,9 -16,4 -8.62% | -18,9 -15,9 -18.69% | -18,8 -18,4 -1.94% | -20,8 -17,7 -17.66% | -12,9 -16,5 21.68% | -10,8 -13,2 18.23% | -23,4 -14,1 -66.5% | -13,5 | -9,18 | -6,23 | -10,8 | -9,13 |
Net income Million USD | Released Forecast Spread | -16,4 -14,2 -15.76% | -17,5 -13,4 -30.32% | -17,9 -16,5 -8.03% | -18,9 -16,0 -17.99% | -18,8 -18,7 -0.45% | -20,8 -17,8 -16.93% | -12,9 -16,5 21.55% | -10,8 -13,8 21.65% | -23,5 -14,3 -64.48% | -13,9 | -9,89 | -6,96 | -11,7 | -9,85 |
EPS USD | Released Forecast Spread | -0,44 -0,39 -13.55% | -0,47 -0,37 -26.34% | -0,47 -0,44 -6.82% | -0,50 -0,44 -13.31% | -0,49 -0,49 -0.75% | -0,51 -0,46 -10.99% | -0,26 -0,36 28.63% | -0,22 -0,28 21.02% | -0,48 -0,29 -66.23% | -0,29 | -0,19 | -0,14 | -0,22 | -0,17 |
Announcement Date | 05/05/22 | 08/08/22 | 07/11/22 | 06/03/23 | 08/05/23 | 07/08/23 | 08/11/23 | 04/03/24 | 13/05/24 | - | - | - | - | - |
Past sector events for Akoya Biosciences, Inc.
2024-05-14 | FUKUDA DENSHI CO., LTD.: Q4 2023 Earnings Release |
2024-05-12 | NIHON KOHDEN CORPORATION: Q4 2023 Earnings Release |
2024-05-09 | OLYMPUS CORPORATION: Q4 2024 Earnings Release |
2024-05-08 | JEISYS MEDICAL INC.: Q1 2024 Earnings Release (Projected) |
2024-05-08 04:05 pm | CYTEK BIOSCIENCES, INC.: Q1 2024 Earnings Release |
2024-05-08 04:01 pm | STANDARD BIOTOOLS INC.: Q1 2024 Earnings Release |
2024-05-08 01:00 am | CARL ZEISS MEDITEC AG: Q2 2024 Earnings Release |
2024-05-07 | CLASSYS INC.: Q1 2024 Earnings Release |
2024-05-07 04:00 pm | QUANTERIX CORPORATION: Q1 2024 Earnings Release |
2024-05-07 06:50 am | WATERS CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AKYA Stock
- Calendar Akoya Biosciences, Inc.